1. Home
  2. MDXG vs ROOT Comparison

MDXG vs ROOT Comparison

Compare MDXG & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • ROOT
  • Stock Information
  • Founded
  • MDXG 2006
  • ROOT 2015
  • Country
  • MDXG United States
  • ROOT United States
  • Employees
  • MDXG N/A
  • ROOT N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • ROOT Property-Casualty Insurers
  • Sector
  • MDXG Health Care
  • ROOT Finance
  • Exchange
  • MDXG Nasdaq
  • ROOT Nasdaq
  • Market Cap
  • MDXG 1.1B
  • ROOT 2.3B
  • IPO Year
  • MDXG N/A
  • ROOT 2020
  • Fundamental
  • Price
  • MDXG $7.09
  • ROOT $99.78
  • Analyst Decision
  • MDXG Buy
  • ROOT Buy
  • Analyst Count
  • MDXG 1
  • ROOT 6
  • Target Price
  • MDXG $12.00
  • ROOT $130.60
  • AVG Volume (30 Days)
  • MDXG 439.7K
  • ROOT 439.3K
  • Earning Date
  • MDXG 10-29-2025
  • ROOT 10-29-2025
  • Dividend Yield
  • MDXG N/A
  • ROOT N/A
  • EPS Growth
  • MDXG N/A
  • ROOT N/A
  • EPS
  • MDXG 0.21
  • ROOT 4.73
  • Revenue
  • MDXG $363,774,000.00
  • ROOT $1,364,700,000.00
  • Revenue This Year
  • MDXG $12.68
  • ROOT $27.41
  • Revenue Next Year
  • MDXG $8.18
  • ROOT $9.74
  • P/E Ratio
  • MDXG $32.78
  • ROOT $20.12
  • Revenue Growth
  • MDXG 6.85
  • ROOT 59.76
  • 52 Week Low
  • MDXG $5.47
  • ROOT $36.87
  • 52 Week High
  • MDXG $10.14
  • ROOT $181.14
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 51.49
  • ROOT 52.54
  • Support Level
  • MDXG $6.89
  • ROOT $94.78
  • Resistance Level
  • MDXG $7.13
  • ROOT $102.47
  • Average True Range (ATR)
  • MDXG 0.18
  • ROOT 4.63
  • MACD
  • MDXG -0.02
  • ROOT 1.56
  • Stochastic Oscillator
  • MDXG 61.36
  • ROOT 81.68

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About ROOT Root Inc.

Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.

Share on Social Networks: